Citi Downgrades Clovis, Rates It As High Risk By: Benzinga via Benzinga June 04, 2014 at 08:32 AM EDT Citi analyst Yaron Werber downgraded Clovis Oncology (NASDAQ: CLVS) to Neutral/High Risk and issued a new price target of ... Read More >> Related Stocks: Clovis Oncology Inc